This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) | MicrobiomeTrials
← Back to trials NCT07242248
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-11-17Est. Completion: 2029-03-05
Enrollment target: 220 participantsLocations London North West University Healthcare NHS Trust, Harrow, United Kingdom Other microbiome trials you might be interested in Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United States Est. completion Jun 1, 2036
Type 2 Diabetes Diabetes Mellitus Type 2
AIM-MET is a randomized clinical study testing whether a fixed microbiome-targeted nutritional product can improve blood…
Izmir, Turkey (Türkiye) Est. completion Mar 30, 2027
Recruiting
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United States Est. completion Sep 1, 2026